Literature DB >> 19254755

Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes.

Matthieu Fisichella1, Hinda Dabboue, Sanjib Bhattacharyya, Marie-Louise Saboungi, Jean-Paul Salvetat, Tobias Hevor, Martine Guerin.   

Abstract

We report on the observation that mesoporous silica nanoparticles (MSNs), after being endocytosed, interfere with the MTT test in HeLa cells and astrocytes by accelerating the exocytosis of formazan crystals. The stimulation of MTT formazan exocytosis is probably related to perturbation of intracellular vesicle trafficking by MSN uptake as revealed by experiments in presence of chloroquine and genistein. Similar effect has been previously observed with a number of chemicals, especially with neurotoxic beta amyloid peptides, but not with nanoparticles. We showed also that MTT reduction test gives an overestimation of the cytotoxicity of mesoporous silica nanoparticles compared to other tests such as LDH activity, WST-1 test and flow cytometry. These findings show that MTT assay should not be used for the study of MSN toxicity, and that perturbation of intracellular trafficking has to be taken into account in evaluating biocompatibility of MSNs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254755     DOI: 10.1016/j.tiv.2009.02.007

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  24 in total

1.  Mitotic trafficking of silicon microparticles.

Authors:  Rita E Serda; Silvia Ferrati; Biana Godin; Ennio Tasciotti; XueWu Liu; Mauro Ferrari
Journal:  Nanoscale       Date:  2009-10-05       Impact factor: 7.790

2.  Autophagy upregulation promotes macrophages to escape mesoporous silica nanoparticle (MSN)-induced NF-κB-dependent inflammation.

Authors:  Chen Xi; Jie Zhou; Shuzhang Du; Shaojun Peng
Journal:  Inflamm Res       Date:  2016-02-09       Impact factor: 4.575

3.  An in situ synthesis of mesoporous SBA-16/hydroxyapatite for ciprofloxacin release: in vitro stability and cytocompatibility studies.

Authors:  Gracielle Ferreira Andrade; Viviane Silva Gomide; Armando Cunha da Silva Júnior; Alfredo Miranda Goes; Edésia Martins Barros de Sousa
Journal:  J Mater Sci Mater Med       Date:  2014-07-24       Impact factor: 3.896

Review 4.  The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.

Authors:  Robert Roggers; Shrey Kanvinde; Suthida Boonsith; David Oupický
Journal:  AAPS PharmSciTech       Date:  2014-05-29       Impact factor: 3.246

5.  Cerium dioxide (CeO2) nanoparticles decrease arsenite (As(III)) cytotoxicity to 16HBE14o- human bronchial epithelial cells.

Authors:  Chao Zeng; Chi Nguyen; Scott Boitano; Jim A Field; Farhang Shadman; Reyes Sierra-Alvarez
Journal:  Environ Res       Date:  2018-03-22       Impact factor: 6.498

6.  Kinetics of silica nanoparticles in the human placenta.

Authors:  Marie Sønnegaard Poulsen; Tina Mose; Lisa Leth Maroun; Line Mathiesen; Lisbeth Ehlert Knudsen; Erik Rytting
Journal:  Nanotoxicology       Date:  2013-07-01       Impact factor: 5.913

Review 7.  Handling of iron oxide and silver nanoparticles by astrocytes.

Authors:  Michaela C Hohnholt; Mark Geppert; Eva M Luther; Charlotte Petters; Felix Bulcke; Ralf Dringen
Journal:  Neurochem Res       Date:  2012-12-06       Impact factor: 3.996

8.  Intestinal toxicity evaluation of TiO2 degraded surface-treated nanoparticles: a combined physico-chemical and toxicogenomics approach in caco-2 cells.

Authors:  Matthieu Fisichella; Frederic Berenguer; Gerard Steinmetz; Melanie Auffan; Jerome Rose; Odette Prat
Journal:  Part Fibre Toxicol       Date:  2012-05-31       Impact factor: 9.400

Review 9.  The nanosilica hazard: another variable entity.

Authors:  Dorota Napierska; Leen C J Thomassen; Dominique Lison; Johan A Martens; Peter H Hoet
Journal:  Part Fibre Toxicol       Date:  2010-12-03       Impact factor: 9.400

10.  Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: which tests and what protocols?

Authors:  Clare Hoskins; Lijun Wang; Woei Ping Cheng; Alfred Cuschieri
Journal:  Nanoscale Res Lett       Date:  2012-01-16       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.